Allspring Global Investments’s Axsome Therapeutics AXSM Stock Holding History

Allspring Global Investments’s Portfolio AXSM Stock Details AXSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15M	Buy	+62,528	New	+$13.6M	0.02%	612
2024 Q4	–	Sell	-9	Closed	-$808	–	1811
2024 Q3	$808	Buy	+9	New	+$786	﹤0.01%	2342
2023 Q4	–	Sell	-103,721	Closed	-$7.25M	–	2260
2023 Q3	$7.25M	Buy	103,721 +1,108	+1%	+$82.8K	0.01%	843
2023 Q2	$7.37M	Buy	102,613 +101,027	+6,370%	+$7.45M	0.01%	874
2023 Q1	$97.8K	Sell	1,586 -804	-34%	-$52.8K	﹤0.01%	2056
2022 Q4	$184K	Buy	2,390 +3	+0.1%	+$179	﹤0.01%	1850
2022 Q3	$106K	Sell	2,387 -1,318	-36%	-$65.9K	﹤0.01%	2061
2022 Q2	$141K	Buy	3,705 +284	+8%	+$8.98K	﹤0.01%	1938
2022 Q1	$141K	Buy	+3,421	New	+$106K	﹤0.01%	2673

Other funds holding AXSM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Allspring Global Investments's AXSM Position: Q2 2026 in Review

Allspring Global Investments opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 62,528 shares worth $15M. The stake represents 0.02% of the portfolio and ranks #612 among its holdings. This is a return to the name: Allspring Global Investments previously reported a position in AXSM as recently as Q3 2024.

Allspring Global Investments first reported a position in AXSM in Q1 2022 and has held it in 9 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

Allspring Global Investments held 62,528 shares of Axsome Therapeutics worth $15M as of Q2 2026.
Axsome Therapeutics was a new Allspring Global Investments position in Q2 2026.
Axsome Therapeutics made up 0.02% of Allspring Global Investments's portfolio in Q2 2026, its #612 holding.
Allspring Global Investments first reported a position in Axsome Therapeutics in Q1 2022 and has held it in 9 quarters since.
506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.